Innovative Research Award
| Neeraj Thakur | |
|---|---|
| Affiliation | University of Oklahoma Health Campus |
| Country | United States |
| Scopus ID | 56645996700 |
| Documents | 37 |
| Citations | 1,149 |
| h-index | 20 |
| Subject Area | Pharmacology, Toxicology and Pharmaceutical Science |
| Event | International Academic Achievements & Awards |
| ORCID | 0000-0003-1758-0737 |
Neeraj Thakur
University of Oklahoma Health Campus, United States
The Innovative Research Award recognizes sustained scholarly excellence, impactful scientific contributions, and innovation in biomedical and pharmaceutical sciences. Neeraj Thakur has established an active research profile focused on advanced drug delivery systems, nanomedicine, pharmaceutical formulations, biomaterials, and translational therapeutic technologies. His published work demonstrates interdisciplinary collaboration across pharmaceutical science, toxicology, and biomedical engineering while contributing to improved therapeutic delivery strategies for dermatological and ocular applications.[1]
Contents
Abstract
Neeraj Thakur’s research integrates pharmaceutical sciences, nanotechnology, biomaterials, and targeted therapeutic delivery to address challenges associated with drug stability, controlled release, tissue targeting, and improved clinical efficacy. His work encompasses hybrid micellar systems, ocular nanoformulations, RNA interference technologies, and advanced pharmaceutical carriers designed to improve patient outcomes through innovative formulation strategies.[2]
Keywords
Drug Delivery Systems, Nanomedicine, Hybrid Micelles, RNA Interference, Corneal Therapeutics, Pharmaceutical Sciences, Targeted Drug Delivery
Introduction
Modern pharmaceutical research increasingly focuses on precision drug delivery, sustained therapeutic release, and biomaterial-enabled treatment strategies. Neeraj Thakur’s research aligns with these objectives through the development of multifunctional nanocarriers and advanced pharmaceutical formulations capable of enhancing therapeutic performance while minimizing adverse effects. His publications demonstrate an interdisciplinary approach combining pharmaceutical sciences with materials engineering and translational medicine.[3]
Research Profile
- Scopus Author ID: 56645996700
- 37 indexed scholarly publications.
- 1,149 citations reflecting broad scientific visibility.
- h-index of 20 demonstrating consistent research influence.
- Research spans pharmacology, toxicology, pharmaceutical sciences, nanomedicine and biomaterials.
Research Contributions
The research contributions of Neeraj Thakur include the design of crosslinked hybrid micellar systems for cutaneous drug delivery, sustained nanoformulations for corneal wound healing, and RNA interference applications in viral diagnostics and therapeutics. These investigations emphasize formulation optimization, targeted delivery, therapeutic efficiency, and translational biomedical applications while supporting the broader advancement of pharmaceutical technology.[4]
Publications
- Crosslinked hybrid micellar platform for targeted cutaneous drug delivery
Colloids and Surfaces B: Biointerfaces (2026). DOI: 10.1016/j.colsurfb.2026.115998 - Crosslinked Hybrid Micellar Platform for Targeted Cutaneous Drug Delivery
Preprint (2026). DOI: 10.2139/ssrn.6250431 - A multimodal approach to smart and sustained drug delivery for corneal wound management: the GelPol nanoformulation
Nanomedicine (2025). DOI: 10.1080/17435889.2025.2550236 - RNAi in viral control and diagnostics
Book Chapter (2025). DOI: 10.1088/978-0-7503-4987-1ch12
Research Impact
The documented citation profile, publication record, and interdisciplinary research portfolio indicate sustained academic influence within pharmaceutical sciences. Contributions toward targeted drug delivery technologies and nanomedicine support ongoing developments in precision therapeutics, controlled release formulations, and biomedical innovation. The citation metrics further demonstrate recognition by the international research community.[1]
Award Suitability
Based on the available scholarly metrics, publication output, interdisciplinary research contributions, and demonstrated impact within pharmaceutical sciences, Neeraj Thakur represents a suitable candidate for recognition through the Innovative Research Award. His research portfolio reflects innovation in drug delivery technologies, sustained scientific productivity, and contributions supporting future translational healthcare solutions.[2]
Conclusion
Neeraj Thakur has established a notable research profile characterized by innovation in pharmaceutical formulation science, targeted therapeutic delivery, nanotechnology, and biomaterial-based treatment strategies. Supported by strong bibliometric indicators and peer-reviewed scholarly publications, his work contributes to the continued advancement of pharmaceutical sciences and biomedical research while reflecting the qualities recognized by the Innovative Research Award.[4]
External Links
References
- Elsevier. (n.d.). Scopus author details: Neeraj Thakur, Author ID 56645996700. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=56645996700 - Thakur, N. (2026). Crosslinked hybrid micellar platform for targeted cutaneous drug delivery. Colloids and Surfaces B: Biointerfaces.
https://doi.org/10.1016/j.colsurfb.2026.115998 - Thakur, N. (2026). Crosslinked Hybrid Micellar Platform for Targeted Cutaneous Drug Delivery. SSRN Preprint. https://doi.org/10.2139/ssrn.6250431
- Thakur, N. (2025). A multimodal approach to smart and sustained drug delivery for corneal wound management: the GelPol nanoformulation. Nanomedicine. https://doi.org/10.1080/17435889.2025.2550236
- Thakur, N. (2025). RNAi in viral control and diagnostics. Viral Diseases: History and New Developments in Diagnostics and Therapeutics.
https://doi.org/10.1088/978-0-7503-4987-1ch12